Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients.
Jiménez N, Garcia de Herreros M, Reig Ò, Marín-Aguilera M, Aversa C, Ferrer-Mileo L, García-Esteve S, Rodríguez-Carunchio L, Trias I, Font A, Rodriguez-Vida A, Climent MÁ, Cros S, Chirivella I, Domènech M, Figols M, Carles J, Suárez C, Herrero Rivera D, González-Billalabeitia E, Cívico C, Sala-González N, Ruiz de Porras V, Ribal MJ, Prat A, Mellado B. Jiménez N, et al. Among authors: herrero rivera d. Eur Urol Oncol. 2024 Aug;7(4):954-964. doi: 10.1016/j.euo.2023.12.012. Epub 2024 Mar 1. Eur Urol Oncol. 2024. PMID: 38429210 Free article.
Single-nucleotide polymorphism associations with efficacy and toxicity in metastatic castration-resistant prostate cancer treated with cabazitaxel.
Herrero Rivera D, Vacas CG, Kovandzic LM, Vázquez JP, Alonso LA, González BM, Aragón VC, Grande E, Caro RL, Virizuela Echaburu JA, Rodríguez Moreno JF, Etxebarria AA, Rodríguez-Antona C, Durán I. Herrero Rivera D, et al. Pharmacogenomics. 2022 Jul;23(11):627-638. doi: 10.2217/pgs-2022-0023. Epub 2022 Jul 26. Pharmacogenomics. 2022. PMID: 35880554
Impact of pre-radiation therapy quality of life in lung cancer survival: a prospective, intention-to-treat, multicenter study.
Nieto-Guerrero Gómez JM, Silva Vega GP, Cacicedo J, Delgado León BD, Herrero Rivera D, Praena Fernández JM, Rivin Del Campo E, Ortiz Gordillo MJ, López Guerra JL. Nieto-Guerrero Gómez JM, et al. Among authors: herrero rivera d. Clin Transl Oncol. 2020 Sep;22(9):1635-1644. doi: 10.1007/s12094-020-02310-0. Epub 2020 Feb 18. Clin Transl Oncol. 2020. PMID: 32072471
Association of single nucleotide polymorphisms at HSPB1 rs7459185 and TGFB1 rs11466353 with radiation esophagitis in lung cancer.
Delgado BD, Enguix-Riego MV, Fernández de Bobadilla JC, Herrero Rivera D, Nieto-Guerrero Gómez JM, Praena-Fernández JM, Rivin Del Campo E, Ortiz Gordillo MJ, Fernandez Fernandez MDC, Lopez Guerra JL. Delgado BD, et al. Among authors: herrero rivera d. Radiother Oncol. 2019 Jun;135:161-169. doi: 10.1016/j.radonc.2019.03.005. Epub 2019 Mar 27. Radiother Oncol. 2019. PMID: 31015163
The single nucleotide variant rs2868371 associates with the risk of mortality in non-small cell lung cancer patients: A multicenter prospective validation.
Enguix-Riego MDV, Cacicedo J, Delgado León BD, Nieto-Guerrero Gómez JM, Herrero Rivera D, Perez M, Praena-Fernández JM, Sanchez Carmona G, Rivin Del Campo E, Ortiz Gordillo MJ, Lopez Guerra JL. Enguix-Riego MDV, et al. Among authors: herrero rivera d. Radiother Oncol. 2019 Jul;136:29-36. doi: 10.1016/j.radonc.2019.03.025. Epub 2019 Apr 6. Radiother Oncol. 2019. PMID: 31015126
Cardiovascular disease and survival in non-small cell lung cancer: a multicenter prospective assessment.
Herrero Rivera D, Nieto-Guerrero Gómez JM, Cacicedo Fernández de Bobadilla J, Delgado D, Rivin Del Campo E, Praena-Fernández JM, Bernabé Caro R, Ortiz Gordillo MJ, Fernández Fernández MC, Lopez Guerra JL. Herrero Rivera D, et al. Clin Transl Oncol. 2019 Sep;21(9):1220-1230. doi: 10.1007/s12094-019-02047-5. Epub 2019 Jan 24. Clin Transl Oncol. 2019. PMID: 30680608